Contraceptive prevalence, any modern method in Guinea
Guinea: Contraceptive prevalence, any modern method was 10.6% in 2018. ◆ Volatile
Contraceptive prevalence, any modern method in Guinea, 1992–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
In 2018, contraceptive prevalence, any modern method in Guinea stood at 10.6%. That is the highest value across all 6 years on record.
The figure is up 36.7% on the previous year and up 86.0% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Guinea peaked at 10.6% in 2018 and was at its lowest, 1.0%, in 1992.
That places Guinea 111th out of 113 countries with data for 2018, putting it in the bottom quarter.
Contraceptive prevalence, any modern method in Guinea, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1992 | 1.0% | — |
| 1999 | 4.2% | +320.0% |
| 2005 | 5.7% | +35.7% |
| 2012 | 4.6% | -19.3% |
| 2016 | 7.8% | +68.6% |
| 2018 | 10.6% | +36.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 2.6% | 1.0% | 4.2% | 2 |
| 2000s | 5.7% | 5.7% | 5.7% | 1 |
| 2010s | 7.7% | 4.6% | 10.6% | 3 |
Countries ranked near Guinea
More health data for Guinea
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8529 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,123 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11,190 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 113 (2025)
- Population ages 00-04, female, annual growth rate 0.9852 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0731 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9785 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Guinea?
- Contraceptive prevalence, any modern method in Guinea was 10.6% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Guinea?
- The highest recorded value was 10.6% in 2018.
- What is the lowest contraceptive prevalence, any modern method recorded in Guinea?
- The lowest recorded value was 1.0% in 1992.
- How does Guinea rank for contraceptive prevalence, any modern method?
- Guinea ranks 111th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Guinea?
- Over the last ten years it is up 86.0%. The long-run trend across the full record is volatile.
- Where does this Guinea data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.